ClinVar Miner

Submissions for variant NM_000702.4(ATP1A2):c.3027T>A (p.Tyr1009Ter)

dbSNP: rs1570998206
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital RCV000853535 SCV000995917 likely pathogenic Epilepsy 2019-10-04 criteria provided, single submitter clinical testing
Invitae RCV001858518 SCV002128985 pathogenic Familial hemiplegic migraine 2022-02-11 criteria provided, single submitter clinical testing Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Experimental studies have shown that this premature translational stop signal affects ATP1A2 function (PMID: 24921013). ClinVar contains an entry for this variant (Variation ID: 692197). This premature translational stop signal has been observed in individual(s) with familial hemiplegic migraine (PMID: 18644608). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr1009*) in the ATP1A2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 12 amino acid(s) of the ATP1A2 protein.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.